Clinical Trials Browser

Phase 3 × Neurotoxicity Syndromes × Gabapentin × Clear all

NCT00027963 2016-07-04

Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy

Phase 3 Completed

Pain, Neurotoxicity Syndromes